Lifeward (LFWD) Stock Overview
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
LFWD Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Lifeward Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.55 |
| 52 Week High | US$4.00 |
| 52 Week Low | US$0.50 |
| Beta | 0.0089 |
| 1 Month Change | -28.82% |
| 3 Month Change | -20.82% |
| 1 Year Change | -75.72% |
| 3 Year Change | -91.74% |
| 5 Year Change | -92.81% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Even With A 27% Surge, Cautious Investors Are Not Rewarding Lifeward Ltd.'s (NASDAQ:LFWD) Performance Completely
Sep 25
Many Still Looking Away From Lifeward Ltd. (NASDAQ:LFWD)
Jun 19
AlterG NEO And ReWalk 70 Will Shape Future Market Opportunities
Established lump sum payments and expanded into U.S. workers' compensation, creating stable revenue streams and improving net margins through efficient claim processing.Market Cool On Lifeward Ltd.'s (NASDAQ:LFWD) Revenues Pushing Shares 50% Lower
Feb 05Not Many Are Piling Into Lifeward Ltd. (NASDAQ:LFWD) Stock Yet As It Plummets 25%
Oct 30Here's Why Lifeward (NASDAQ:LFWD) Must Use Its Cash Wisely
Oct 15ReWalk Robotics Ltd. (NASDAQ:LFWD) Soars 26% But It's A Story Of Risk Vs Reward
Aug 01Is ReWalk Robotics (NASDAQ:LFWD) In A Good Position To Deliver On Growth Plans?
May 30Investors Give ReWalk Robotics Ltd. (NASDAQ:LFWD) Shares A 28% Hiding
Mar 14We Think ReWalk Robotics (NASDAQ:RWLK) Needs To Drive Business Growth Carefully
Jan 09Shareholders May Be A Bit More Conservative With ReWalk Robotics Ltd.'s (NASDAQ:RWLK) CEO Compensation For Now
Sep 06Is ReWalk Robotics (NASDAQ:RWLK) In A Good Position To Deliver On Growth Plans?
Jul 04Is ReWalk Robotics (NASDAQ:RWLK) In A Good Position To Invest In Growth?
Mar 07Shareholder Returns
| LFWD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -16.3% | -1.5% | -2.1% |
| 1Y | -75.7% | -0.3% | 17.2% |
Return vs Industry: LFWD underperformed the US Medical Equipment industry which returned -0.3% over the past year.
Return vs Market: LFWD underperformed the US Market which returned 20.1% over the past year.
Price Volatility
| LFWD volatility | |
|---|---|
| LFWD Average Weekly Movement | 10.8% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LFWD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: LFWD's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 80 | William Grant | golifeward.com |
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals’ post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.
Lifeward Ltd. Fundamentals Summary
| LFWD fundamental statistics | |
|---|---|
| Market cap | US$9.13m |
| Earnings (TTM) | -US$29.76m |
| Revenue (TTM) | US$24.43m |
Is LFWD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFWD income statement (TTM) | |
|---|---|
| Revenue | US$24.43m |
| Cost of Revenue | US$16.08m |
| Gross Profit | US$8.35m |
| Other Expenses | US$38.11m |
| Earnings | -US$29.76m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.89 |
| Gross Margin | 34.17% |
| Net Profit Margin | -121.80% |
| Debt/Equity Ratio | 0% |
How did LFWD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/04 07:15 |
| End of Day Share Price | 2025/11/04 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lifeward Ltd. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Taylor | Barclays |
| William Plovanic | Canaccord Genuity |
| Swayampakula Ramakanth | H.C. Wainwright & Co. |